Can Ondansetron be an Alternative to Cabergoline for Preventing Ovarian Hyperstimulation Syndrome?

Bakirci, SukruKurdoglu, MertihanKhaki, Arash2025-01-212025-01-2120232330-4456https://doi.org/10.15296/ijwhr.2023.09https://hdl.handle.net/20.500.12587/24292[Abstract No tAvailable]eninfo:eu-repo/semantics/openAccessCan Ondansetron be an Alternative to Cabergoline for Preventing Ovarian Hyperstimulation Syndrome?Editorial112444410.15296/ijwhr.2023.092-s2.0-85153191700Q3WOS:000964287000001Q4